Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT04413227
Status:
UNKNOWN
Last Update Posted:
2020-06-02
First Post:
2020-05-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-25
First Submit QC Date:
None
Study First Post Date:
2020-06-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-28
Last Update Post Date:
2020-06-02
Last Update Post Date Type:
ACTUAL